Syngene International Ltd
NSE :SYNGENE BSE :539268 Sector : HealthcareBuy, Sell or Hold SYNGENE? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
19 Nov 850.80 (0.96%) | 18 Nov 842.75 (-2.19%) | 14 Nov 861.60 (-0.13%) | 13 Nov 862.75 (-2.99%) | 12 Nov 889.30 (0.06%) | 11 Nov 888.75 (-1.08%) | 08 Nov 898.45 (-1.65%) | 07 Nov 913.50 (1.07%) | 06 Nov 903.85 (4.16%) | 05 Nov 867.75 (0.29%) | 04 Nov 865.20 (0.45%) | 01 Nov 861.35 (0.13%) | 31 Oct 860.25 (-0.19%) | 30 Oct 861.85 (1.48%) | 29 Oct 849.25 (-2.53%) | 28 Oct 871.30 (-0.41%) | 25 Oct 874.85 (-0.56%) | 24 Oct 879.75 (5.13%) | 23 Oct 836.85 (-0.22%) | 22 Oct 838.70 (-1.92%) | 21 Oct 855.15 (-2.54%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bearish
Medium Term Investors
Very Bearish
Long Term Investors
Bullish
Moving Averages
5 DMA
Bearish
860.79
10 DMA
Bearish
877.69
20 DMA
Bearish
868.78
50 DMA
Bearish
883.12
100 DMA
Bullish
840.43
200 DMA
Bullish
772.95
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Nov 19, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 877.4 | 869.8 | 855.5 | - | - |
R2 | 869.8 | 863.27 | 853.94 | 869.33 | - |
R1 | 860.3 | 859.23 | 852.37 | 859.36 | 865.05 |
P | 852.7 | 852.7 | 852.7 | 852.23 | 855.08 |
S1 | 843.2 | 846.17 | 849.23 | 842.26 | 847.95 |
S2 | 835.6 | 842.13 | 847.67 | 835.13 | - |
S3 | 826.1 | 835.6 | 846.1 | - | - |
Key Metrics
EPS
10.91
P/E
77.93
P/B
7.93
Dividend Yield
0.15%
Market Cap
34,248 Cr.
Face Value
10
Book Value
107.28
ROE
12.95%
EBITDA Growth
260.3 Cr.
Debt/Equity
0.17
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Syngene International Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 931.7 | 882.8 | 933 | 839.8 | 907.5 |
PROFIT | 122.22 | 114.49 | 188.6 | 51.79 | 106.1 |
EPS | 2.9 | 2.78 | 4.7 | 1.89 | 2.64 |
Syngene International Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 851.7 | 820.7 | 880 | 776.2 | 837.7 |
PROFIT | 107.35 | 102.76 | 189.8 | 49.96 | 96.6 |
EPS | 2.53 | 2.49 | 4.73 | 1.84 | 2.41 |
Profit & Loss (Figures in Rs. Crores)
Syngene International Ltd Profit & Loss
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 1498.4 | 1874.7 | 2164 | 2309.1 | 2678.6 | 3305.8 | 3522.6 | |
PROFIT | 289.35 | 328.12 | 358.49 | 379.76 | 417.63 | 470.41 | 520.91 | |
EPS | 7.64 | 8.29 | 10.3 | 10.12 | 9.88 | 11.57 | 12.69 |
Syngene International Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 881.9 | 1117.7 | 1293.9 | 1498.4 | 1874.7 | 2164 | 2304.2 | 2730.6 | 3306.4 | 3234.5 | |
PROFIT | 175 | 240.8 | 286.74 | 289.05 | 327.22 | 357.85 | 378.54 | 415.64 | 470.5 | 466.99 | |
EPS | 7.82 | 5.92 | 7.19 | 7.63 | 8.27 | 10.29 | 10.09 | 9.83 | 11.78 | 11.6 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
SOURCES OF FUNDS : | |||||||
Share Capital | 402 | 401.4 | 400.8 | 400 | 400 | 200 | 200 |
Reserves Total | 3,855.8 | 3,216.6 | 2,896.8 | 2,421.4 | 1,775.8 | 1,768.4 | 1,520.4 |
Total Shareholders Funds | 4,257.8 | 3,618 | 3,297.6 | 2,821.4 | 2,175.8 | 1,968.4 | 1,720.4 |
Secured Loans | 141.7 | 575.3 | 531.5 | 512.4 | 376.7 | 606.6 | 692.6 |
Unsecured Loans | 413.5 | 239.9 | 490.1 | 380.5 | 396.2 | 206.7 | 94.8 |
Total Debt | 555.2 | 815.2 | 1,021.6 | 892.9 | 772.9 | 813.3 | 787.4 |
Other Liabilities | 284.5 | 321.6 | 295.6 | 311.2 | 366.7 | 244.8 | 99.5 |
Total Liabilities | 5,097.5 | 4,754.8 | 4,614.8 | 4,025.5 | 3,315.4 | 3,026.5 | 2,607.3 |
APPLICATION OF FUNDS : | |||||||
Gross Block | 5,011.6 | 4,546.9 | 3,943.5 | 3,460 | 3,017.2 | 2,171 | 1,660.7 |
Less: Accumulated Depreciation | 2,161.6 | 1,880 | 1,550.7 | 1,259 | 997.5 | 794.2 | 630.3 |
Net Block | 2,850 | 2,666.9 | 2,392.8 | 2,201 | 2,019.7 | 1,376.8 | 1,030.4 |
Capital Work in Progress | 838.1 | 176.9 | 346.4 | 237.2 | 234.1 | 273.7 | 155.4 |
Investments | 547.9 | 918.5 | 1,034.1 | 702 | 776.4 | 716 | 157.7 |
Inventories | 238.5 | 332.8 | 179.4 | 59.6 | 25.2 | 43.4 | 86 |
Sundry Debtors | 441.6 | 529.3 | 507.7 | 475.7 | 398.2 | 338.7 | 266.8 |
Cash and Bank Balance | 563.5 | 531.7 | 517.9 | 642.6 | 281.5 | 436.9 | 967.4 |
Loans and Advances | 202.2 | 207.1 | 237.1 | 205.5 | 169.3 | 229.1 | 242.3 |
Total Current Assets | 1,445.8 | 1,600.9 | 1,442.1 | 1,383.4 | 874.2 | 1,048.1 | 1,562.5 |
Current Liabilities | 933.8 | 1,010.5 | 866.8 | 797.8 | 794.3 | 640.2 | 555.4 |
Provisions | 120.3 | 65.7 | 82.2 | 59.9 | 53.2 | 36.8 | 26.3 |
Total Current Liabilities & Provisions | 1,054.1 | 1,076.2 | 949 | 857.7 | 847.5 | 677 | 581.7 |
Net Current Assets | 391.7 | 524.7 | 493.1 | 525.7 | 26.7 | 371.1 | 980.8 |
Deferred Tax Assets | 182.6 | 194.1 | 190.7 | 188.9 | 208.3 | 124.6 | 118.4 |
Deferred Tax Liability | 141.9 | 124.5 | 125.1 | 99.8 | 85.6 | 33.1 | 46 |
Net Deferred Tax | 40.7 | 69.6 | 65.6 | 89.1 | 122.7 | 91.5 | 72.4 |
Other Assets | 429.1 | 398.2 | 282.8 | 270.5 | 135.8 | 197.4 | 210.6 |
Total Assets | 5,097.5 | 4,754.8 | 4,614.8 | 4,025.5 | 3,315.4 | 3,026.5 | 2,607.3 |
Contingent Liabilities | 1,269.2 | 1,243.8 | 1,095.6 | 859.6 | 424.7 | 335.9 | 476.8 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 402 | 401.4 | 400.8 | 400 | 400 | 200 | 200 | 200 | 200 | 199.1 |
Reserves Total | 3,789.5 | 3,217.5 | 2,891.2 | 2,418.3 | 1,774.1 | 1,767.2 | 1,520.1 | 1,224.4 | 824.7 | 645.8 |
Equity Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.3 | 0 | 0 |
Total Shareholders Funds | 4,191.5 | 3,618.9 | 3,292 | 2,818.3 | 2,174.1 | 1,967.2 | 1,720.1 | 1,413.1 | 1,024.7 | 844.9 |
Secured Loans | 141.7 | 575.3 | 531.5 | 512.4 | 376.7 | 606.6 | 692.6 | 689.8 | 891 | 18.6 |
Unsecured Loans | 190.7 | 63.3 | 490.1 | 380.5 | 396.2 | 206.7 | 94.8 | 116.6 | 0 | 136.4 |
Total Debt | 332.4 | 638.6 | 1,021.6 | 892.9 | 772.9 | 813.3 | 787.4 | 806.4 | 891 | 155 |
Other Liabilities | 281.9 | 319.6 | 295.6 | 311.2 | 366.7 | 244.8 | 99.5 | 71.6 | 71.6 | 77.9 |
Total Liabilities | 4,805.8 | 4,577.1 | 4,609.2 | 4,022.4 | 3,313.7 | 3,025.3 | 2,607 | 2,291.1 | 1,987.3 | 1,077.8 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 4,371 | 4,070.7 | 3,943.5 | 3,460 | 3,017.2 | 2,171 | 1,660.7 | 1,331.9 | 1,111.4 | 938 |
Less : Accumulated Depreciation | 2,053.1 | 1,810.8 | 1,550.7 | 1,259 | 997.5 | 794.2 | 630.3 | 521.5 | 531.2 | 434.7 |
Net Block | 2,317.9 | 2,259.9 | 2,392.8 | 2,201 | 2,019.7 | 1,376.8 | 1,030.4 | 810.4 | 580.2 | 503.3 |
Capital Work in Progress | 759.6 | 126.2 | 346.4 | 237.2 | 234.1 | 273.7 | 155.4 | 174.9 | 236.8 | 105.1 |
Investments | 927.6 | 940.8 | 1,034.4 | 702.3 | 776.7 | 716.3 | 158 | 540.4 | 276.6 | 146 |
Inventories | 234 | 332.8 | 179.4 | 59.6 | 25.2 | 43.4 | 86 | 32.2 | 37.7 | 38.4 |
Sundry Debtors | 427.5 | 484.4 | 508.2 | 474.4 | 398.2 | 338.7 | 266.8 | 198.7 | 185.2 | 179.9 |
Cash and Bank Balance | 528.2 | 509.3 | 515.1 | 638.2 | 280.3 | 435.4 | 966.5 | 527.3 | 719.9 | 115.7 |
Loans and Advances | 169.6 | 733.4 | 237.1 | 205.5 | 169.3 | 229.1 | 242.3 | 225.5 | 115.3 | 105.8 |
Total Current Assets | 1,359.3 | 2,059.9 | 1,439.8 | 1,377.7 | 873 | 1,046.6 | 1,561.6 | 983.7 | 1,058.1 | 439.8 |
Current Liabilities | 914.1 | 1,210.1 | 869.4 | 795.3 | 795.1 | 640.2 | 555.2 | 462.5 | 350.8 | 329.4 |
Provisions | 114 | 60.8 | 82.2 | 59.8 | 53.2 | 36.8 | 26.2 | 21.2 | 17.4 | 9.4 |
Total Current Liabilities & Provisions | 1,028.1 | 1,270.9 | 951.6 | 855.1 | 848.3 | 677 | 581.4 | 483.7 | 368.2 | 338.8 |
Net Current Assets | 331.2 | 789 | 488.2 | 522.6 | 24.7 | 369.6 | 980.2 | 500 | 689.9 | 101 |
Deferred Tax Assets | 178.3 | 201.6 | 190.3 | 188.5 | 208.3 | 124.6 | 118.4 | 97.2 | 84.5 | 5.1 |
Deferred Tax Liability | 128.5 | 122.1 | 125.2 | 99.8 | 85.6 | 33.1 | 46 | 33.5 | 12.8 | 10 |
Net Deferred Tax | 49.8 | 79.5 | 65.1 | 88.7 | 122.7 | 91.5 | 72.4 | 63.7 | 71.7 | -4.9 |
Other Assets | 419.7 | 381.7 | 282.3 | 270.6 | 135.8 | 197.4 | 210.6 | 201.7 | 132.1 | 227.3 |
Total Assets | 4,805.8 | 4,577.1 | 4,609.2 | 4,022.4 | 3,313.7 | 3,025.3 | 2,607 | 2,291.1 | 1,987.3 | 1,077.8 |
Contingent Liabilities | 1,264.2 | 1,243.8 | 547.8 | 859.6 | 849.2 | 671.6 | 238.5 | 376.6 | 384.9 | 110.4 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 510 |
Depreciation | 425.9 |
Interest (Net) | -15.2 |
P/L on Sales of Invest | -14.4 |
Prov. and W/O (Net) | -14.8 |
P/L in Forex | -3.6 |
Total Adjustments (PBT and Ext... | 475.9 |
Operating Profit before Workin... | 985.9 |
Trade and 0ther Receivables | 86.7 |
Inventories | 114.6 |
Trade Payables | -102.7 |
Total Adjustments (OP before W... | 181.3 |
Cash Generated from/(used in) ... | 1,167.2 |
Direct Taxes Paid | -125.1 |
Total Adjustments(Cash Generat... | -125.1 |
Cash Flow before Extraordinary... | 1,042.1 |
Net Cash from Operating Activi... | 1,042.1 |
Purchased of Fixed Assets | -510.8 |
Sale of Fixed Assets | 22.1 |
Purchase of Investments | -2,804 |
Sale of Investments | 2,735.2 |
Interest Received | 81.5 |
Net Cash used in Investing Act... | -494.4 |
Of the Long Tem Borrowings | -390.4 |
Of the Short Term Borrowings | -45.2 |
Of Financial Liabilities | -36.8 |
Dividend Paid | -50.3 |
Interest Paid | -28.8 |
Net Cash used in Financing Act... | -551.5 |
Net Profit before Tax and Extr... | 466.5 |
Depreciation | 368.9 |
Interest (Net) | -31.6 |
P/L on Sales of Invest | -13 |
Prov. and W/O (Net) | -17.8 |
P/L in Forex | -3.3 |
Total Adjustments (PBT and Ext... | 380 |
Operating Profit before Workin... | 846.5 |
Trade and 0ther Receivables | 58.8 |
Inventories | 119.1 |
Trade Payables | -116.6 |
Total Adjustments (OP before W... | 165.3 |
Cash Generated from/(used in) ... | 1,011.8 |
Direct Taxes Paid | -98.4 |
Total Adjustments(Cash Generat... | -98.4 |
Cash Flow before Extraordinary... | 913.4 |
Net Cash from Operating Activi... | 913.4 |
Purchased of Fixed Assets | -367.2 |
Sale of Fixed Assets | 21.6 |
Purchase of Investments | -2,944 |
Sale of Investments | 2,516.4 |
Interest Received | 81.2 |
Net Cash used in Investing Act... | -382.6 |
Of the Long Tem Borrowings | -390.4 |
Of the Short Term Borrowings | -45.2 |
Of Financial Liabilities | -32.2 |
Dividend Paid | -50.3 |
Interest Paid | -18.2 |
Net Cash used in Financing Act... | -536.3 |
Company Details
Registered Office |
|
Address | Biocon SEZ Biocon Park, Plot No 2 & 3 Bommasandra Inds |
City | Bengaluru |
State | Karnataka |
Pin Code | 560099 |
Tel. No. | 91-80-68915000/67758781 |
Fax. No. | 91-80-28083189 |
investor@syngeneintl.com; Mayank.Verma@syngeneintl | |
Internet | http://www.syngeneintl.com |
Registrars |
|
Address | Biocon SEZ Biocon Park |
City | Bengaluru |
State | Karnataka |
Pin Code | 560099 |
Tel. No. | 91-80-68915000/67758781 |
Fax. No. | 91-80-28083189 |
investor@syngeneintl.com; Mayank.Verma@syngeneintl | |
Internet | http://www.syngeneintl.com |
Management |
|
Name | Designation |
Kiran Mazumdar Shaw | Chairperson |
Catherine Patricia Rosenberg | Non Executive Director |
Paul Frederick Blackburn | Independent Director |
Vijay Kuchroo | Independent Director |
Jonathan Hunt | Managing Director & CEO |
Vinita Bali | Lead Independent Director |
Priyadarshnini Mahapatra | Company Sec. & Compli. Officer |
Sharmila Karve | Independent Director |
Kush Parmar | Independent Director |
SIBAJI BISWAS | Executive Director & CFO |
Nilanjan Roy | Independent Director |
Manja Boerman | Independent Director |